Carcinoid syndrome surgery: Difference between revisions
(Created page with "{{Carcinoid syndrome}} {{CMG}} ==Overview== ==Surgery== Surgery, if feasible, is the only curative therapy. If the tumour has metastasized (most commonly, to the [[liver...") |
No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
For qualifying candidates, [[surgical]] resection of tumor and [[chemotherapy]] (5-FU and doxorubicin) can improve outcomes. | |||
==Surgery== | ==Surgery== | ||
Revision as of 19:41, 6 August 2012
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome surgery |
|
Risk calculators and risk factors for Carcinoid syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
For qualifying candidates, surgical resection of tumor and chemotherapy (5-FU and doxorubicin) can improve outcomes.
Surgery
Surgery, if feasible, is the only curative therapy. If the tumour has metastasized (most commonly, to the liver), the tumour may be ineligible for surgery (unresectable), though there are many promising treatment modalities, such as radiolabeled octreotide, that are very effective in arresting the growth of the tumours and prolonging survival in patients with liver metastases.